News
Teva UK introduces first generic oral anticoagulant
Teva UK has launched a generic version of apixaban, an oral anticoagulant that directly inhibits factor X – factor Xa – thus restricting thrombin formation and the development of blood clots.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Teva UK has launched a generic version of apixaban, an oral anticoagulant that directly inhibits factor X – factor Xa – thus restricting thrombin formation and the development of blood clots.